Adamax Research Guide: N-Acetyl Semax Amidate Nootropic
Adamax is a modified Semax analog engineered for enhanced enzymatic stability and prolonged central activity in cognitive research models.
What is Adamax?
Adamax is a synthetic hepta-peptide derived from the ACTH(4-10) fragment lineage, with N-terminal acetyl and C-terminal amidate modifications applied to the Semax scaffold. The modifications block aminopeptidase and carboxypeptidase degradation.
Mechanism of action
Adamax shares Semax's mechanism — upregulation of BDNF, NGF, and TrkB signaling in the hippocampus and cortex — but with substantially longer duration of action due to peptidase resistance.
Sourcing & purity
Research-grade material should be ≥99% pure by HPLC with peptide content confirmed via mass spectrometry. Redline Bio material ships with batch documentation; independent third-party COAs are published on the lab reports page as testing returns.
Compliance reminder
Sold and distributed for laboratory research use only. Not approved by the FDA for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
Frequently asked questions
What is Adamax?
Adamax is N-Acetyl Semax Amidate — a modified version of Semax with N-terminal acetylation and C-terminal amidation. These modifications substantially extend enzymatic half-life relative to the parent peptide.
Mechanism?
Like Semax, Adamax is an ACTH(4-7) fragment analog that upregulates BDNF and NGF expression in cortical and hippocampal tissue in animal models. It also modulates dopaminergic and serotonergic signaling.